Landscape Capital Management L.L.C. boosted its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 446.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,996 shares of the company’s stock after buying an additional 10,619 shares during the quarter. Landscape Capital Management L.L.C.’s holdings in Cardinal Health were worth $1,537,000 as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. Cyrus J. Lawrence LLC bought a new stake in shares of Cardinal Health in the fourth quarter worth $26,000. Promus Capital LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth about $30,000. Lee Danner & Bass Inc. bought a new position in shares of Cardinal Health in the 4th quarter valued at about $35,000. Kentucky Trust Co acquired a new stake in shares of Cardinal Health in the fourth quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC raised its holdings in Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock worth $47,000 after acquiring an additional 144 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.
Analyst Ratings Changes
A number of research analysts have weighed in on the company. Mizuho raised their price target on Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a research note on Monday, March 31st. Morgan Stanley boosted their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Wells Fargo & Company boosted their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Finally, Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $140.14.
Cardinal Health Price Performance
CAH stock opened at $129.37 on Friday. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $139.50. The stock has a market capitalization of $31.25 billion, a price-to-earnings ratio of 24.14, a PEG ratio of 1.49 and a beta of 0.66. The business’s fifty day moving average price is $129.15 and its two-hundred day moving average price is $121.55.
Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.56%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 37.69%.
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
- Five stocks we like better than Cardinal Health
- How to start investing in penny stocks
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- ETF Screener: Uses and Step-by-Step Guide
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Consumer Staples Stocks, Explained
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.